{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T04:35:21Z","timestamp":1795062921732,"version":"4.10.2"},"reference-count":59,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100029227","name":"Hanley Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100029227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA240472"],"award-info":[{"award-number":["R01CA240472"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA285856"],"award-info":[{"award-number":["R01CA285856"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R37CA229861"],"award-info":[{"award-number":["R37CA229861"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA217169"],"award-info":[{"award-number":["R01CA217169"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA192399"],"award-info":[{"award-number":["R01CA192399"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA008748"],"award-info":[{"award-number":["P30CA008748"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"DOD","doi-asserted-by":"publisher","award":["LC160212"],"award-info":[{"award-number":["LC160212"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.xcrm.2024.101777","type":"journal-article","created":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T15:38:57Z","timestamp":1729006737000},"page":"101777","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Modeling lung adenocarcinoma metastases using patient-derived organoids"],"prefix":"10.1016","volume":"5","author":[{"given":"Yuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manendra","family":"Lankadasari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Rosiene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kofi E.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samhita","family":"Bapat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai-Fong L.","family":"Chow-Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huasong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Mastrogiacomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry B.","family":"Lengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Caso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth G.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron N.","family":"Fick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Rocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"Sihag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Isbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew J.","family":"Bott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob T.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piro","family":"Lito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron W.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H.","family":"Bilsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Rekhtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad S.","family":"Adusumilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marty W.","family":"Mayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Imielinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2024.101777_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.xcrm.2024.101777_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2020.5601","article-title":"A genomic-pathologic annotated risk model to predict recurrence in early-stage lung adenocarcinoma","volume":"156","author":"Jones","year":"2021","journal-title":"JAMA Surg."},{"key":"10.1016\/j.xcrm.2024.101777_bib3","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature13385","article-title":"Comprehensive molecular profiling of lung adenocarcinoma","volume":"511","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2024.101777_bib4","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1158\/1078-0432.CCR-14-2683","article-title":"Broad, hybrid capture-based next-generation sequencing identifies actionable genomic alterations in lung adenocarcinomas otherwise negative for such alterations by other genomic testing approaches","volume":"21","author":"Drilon","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2024.101777_bib5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41568-018-0007-6","article-title":"Organoids in cancer research","volume":"18","author":"Drost","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2024.101777_bib6","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/s41580-020-0259-3","article-title":"Human organoids: model systems for human biology and medicine","volume":"21","author":"Kim","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.xcrm.2024.101777_bib7","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2018100300","article-title":"Long-term expanding human airway organoids for disease modeling","volume":"38","author":"Sachs","year":"2019","journal-title":"EMBO J."},{"key":"10.1016\/j.xcrm.2024.101777_bib8","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1038\/s41467-019-11867-6","article-title":"Patient-derived lung cancer organoids as in\u00a0vitro cancer models for therapeutic screening","volume":"10","author":"Kim","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101777_bib9","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1158\/1078-0432.CCR-19-1376","article-title":"Organoid cultures as preclinical models of non-small cell lung cancer","volume":"26","author":"Shi","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2024.101777_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107588","article-title":"Challenges in establishing pure lung cancer organoids limit their utility for personalized medicine","volume":"31","author":"Dijkstra","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2024.101777_bib11","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2024.101777_bib12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41698-021-00166-3","article-title":"Clinical application of a lung cancer organoid (tumoroid) culture system","volume":"5","author":"Yokota","year":"2021","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.xcrm.2024.101777_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1472-6890-14-23","article-title":"Ki-67 is a strong prognostic marker of non-small cell lung cancer when tissue heterogeneity is considered","volume":"14","author":"Tabata","year":"2014","journal-title":"BMC Clin. Pathol."},{"key":"10.1016\/j.xcrm.2024.101777_bib14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cell.2020.08.006","article-title":"Distinct classes of complex structural variation uncovered across thousands of cancer genome graphs","volume":"183","author":"Hadi","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101777_bib15","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.cell.2018.03.017","article-title":"Tumor evolution and drug response in patient-derived organoid models of bladder cancer","volume":"173","author":"Lee","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101777_bib16","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.ccell.2023.03.018","article-title":"Genomic mapping of metastatic organotropism in lung adenocarcinoma","volume":"41","author":"Lengel","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2024.101777_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo1050","article-title":"A germline SNP in BRMS1 predisposes patients with lung adenocarcinoma to metastasis and can be ameliorated by targeting c-fos","volume":"14","author":"Liu","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2024.101777_bib18","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.1016\/j.jtho.2018.07.099","article-title":"ARID1A gene driver mutations in lung adenocarcinomas","volume":"13","author":"Karachaliou","year":"2018","journal-title":"J.\u00a0Thorac. Oncol."},{"key":"10.1016\/j.xcrm.2024.101777_bib19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2353\/ajpath.2010.090863","article-title":"Met activation in non-small cell lung cancer is associated with de novo resistance to EGFR inhibitors and the development of brain metastasis","volume":"177","author":"Benedettini","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.xcrm.2024.101777_bib20","doi-asserted-by":"crossref","first-page":"6913","DOI":"10.1158\/0008-5472.CAN-07-5084","article-title":"PIK3CA mutations and copy number gains in human lung cancers","volume":"68","author":"Yamamoto","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2024.101777_bib21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF03401664","article-title":"The CDKN2A (p16) gene and human cancer","volume":"3","author":"Foulkes","year":"1997","journal-title":"Mol. Med."},{"key":"10.1016\/j.xcrm.2024.101777_bib22","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1038\/s41388-022-02184-2","article-title":"Genomic alterations drive metastases formation in pancreatic ductal adenocarcinoma cancer: deciphering the role of CDKN2A and CDKN2B in mediating liver tropism","volume":"41","author":"Journo","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.xcrm.2024.101777_bib23","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1158\/1078-0432.CCR-16-2656","article-title":"Enrichment of PI3K-AKT-mTOR pathway activation in hepatic metastases from breast cancer","volume":"23","author":"Pierobon","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2024.101777_bib24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2024.101777_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.xcrm.2024.101777_bib26","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1158\/0008-5472.CAN-11-1403","article-title":"Identification of genes upregulated in ALK-positive and EGFR\/KRAS\/ALK-negative lung adenocarcinomas","volume":"72","author":"Okayama","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2024.101777_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043923","article-title":"Epidermal growth factor receptor tyrosine kinase defines critical prognostic genes of stage I lung adenocarcinoma","volume":"7","author":"Yamauchi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2024.101777_bib28","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2010.28.15_suppl.10504","article-title":"Use of gene expression signatures to identify origin of primary and therapeutic strategies for patients with advanced solid tumors","volume":"28","author":"Hsu","year":"2010","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.xcrm.2024.101777_bib29","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1056\/NEJMoa2103695","article-title":"Sotorasib for lung cancers with KRAS p.G12C mutation","volume":"384","author":"Skoulidis","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2024.101777_bib30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3892\/ol_00000061","article-title":"Chemosensitivity of lung cancer: differences between the primary lesion and lymph node metastasis","volume":"1","author":"Maniwa","year":"2010","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.xcrm.2024.101777_bib31","first-page":"4453","article-title":"Radiation sensitivity in\u00a0vitro of primary tumors and metastatic lesions of malignant melanoma","volume":"52","author":"Rofstad","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2024.101777_bib32","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41586-021-04065-2","article-title":"Diverse alterations associated with resistance to KRAS(G12C) inhibition","volume":"599","author":"Zhao","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2024.101777_bib33","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nature18600","article-title":"A combinatorial strategy for treating KRAS-mutant lung cancer","volume":"534","author":"Manchado","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2024.101777_bib34","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nm.4041","article-title":"Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma","volume":"22","author":"Ambrogio","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2024.101777_bib35","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41375-018-0248-0","article-title":"Downregulating Notch counteracts Kras(G12D)-induced ERK activation and oxidative phosphorylation in myeloproliferative neoplasm","volume":"33","author":"Kong","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.xcrm.2024.101777_bib36","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S1470-2045(21)00149-2","article-title":"Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial","volume":"22","author":"Altorki","year":"2021","journal-title":"Lancet. Oncol."},{"key":"10.1016\/j.xcrm.2024.101777_bib37","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","article-title":"Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer","volume":"386","author":"Forde","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2024.101777_bib38","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.jtho.2020.06.001","article-title":"A grading system for invasive pulmonary adenocarcinoma: a proposal from the International Association for the Study of Lung Cancer Pathology Committee","volume":"15","author":"Moreira","year":"2020","journal-title":"J.\u00a0Thorac. Oncol."},{"key":"10.1016\/j.xcrm.2024.101777_bib39","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1200\/JCO.2015.60.9818","article-title":"Solid predominant histologic subtype in resected stage I lung adenocarcinoma is an independent predictor of early, extrathoracic, multisite recurrence and of poor postrecurrence survival","volume":"33","author":"Ujiie","year":"2015","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.xcrm.2024.101777_bib40","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.jtho.2020.08.005","article-title":"The underlying tumor genomics of predominant histologic subtypes in lung adenocarcinoma","volume":"15","author":"Caso","year":"2020","journal-title":"J.\u00a0Thorac. Oncol."},{"key":"10.1016\/j.xcrm.2024.101777_bib41","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1101\/gad.1903310","article-title":"The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation","volume":"24","author":"Lian","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.xcrm.2024.101777_bib42","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026203","article-title":"Oncogenic mutant p53 gain of function nourishes the vicious cycle of tumor development and cancer stem-cell formation","volume":"6","author":"Shetzer","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.xcrm.2024.101777_bib43","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.jtcvs.2017.09.151","article-title":"Factors associated with distant recurrence following R0 lobectomy for pN0 lung adenocarcinoma","volume":"155","author":"Brandt","year":"2018","journal-title":"J.\u00a0Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.xcrm.2024.101777_bib44","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1126\/science.1253462","article-title":"Spatial and temporal diversity in genomic instability processes defines lung cancer evolution","volume":"346","author":"de Bruin","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2024.101777_bib45","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s43018-022-00337-6","article-title":"A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology","volume":"3","author":"Guillen","year":"2022","journal-title":"Nat. Can. (Ott.)"},{"key":"10.1016\/j.xcrm.2024.101777_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112324","article-title":"Drug-repurposing screen on patient-derived organoids identifies therapy-induced vulnerability in KRAS-mutant colon cancer","volume":"42","author":"Mertens","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2024.101777_bib47","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S1470-2045(20)30453-8","article-title":"Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial","volume":"21","author":"Provencio","year":"2020","journal-title":"Lancet. Oncol."},{"key":"10.1016\/j.xcrm.2024.101777_bib48","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.cell.2018.11.021","article-title":"Organoid modeling of the tumor immune microenvironment","volume":"175","author":"Neal","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101777_bib49","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.canlet.2021.06.007","article-title":"Hedgehog transcriptional effector GLI mediates mTOR-Induced PD-L1 expression in gastric cancer organoids","volume":"518","author":"Koh","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.xcrm.2024.101777_bib50","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/s41416-019-0616-1","article-title":"Patient-derived organoids as a potential model to predict response to PD-1\/PD-L1 checkpoint inhibitors","volume":"121","author":"Scognamiglio","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.xcrm.2024.101777_bib51","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cell.2018.07.009","article-title":"Generation of tumor-reactive t\u00a0cells by co-culture of peripheral blood lymphocytes and tumor organoids","volume":"174","author":"Dijkstra","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101777_bib52","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1074\/jbc.REV119.007759","article-title":"Cell adhesion in cancer: beyond the migration of single cells","volume":"295","author":"Janiszewska","year":"2020","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xcrm.2024.101777_bib53","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.devcel.2019.03.026","article-title":"The extracellular matrix modulates the metastatic journey","volume":"49","author":"Kai","year":"2019","journal-title":"Dev. Cell"},{"key":"10.1016\/j.xcrm.2024.101777_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aah3941","article-title":"The RNA-editing enzyme ADAR promotes lung adenocarcinoma migration and invasion by stabilizing FAK","volume":"10","author":"Amin","year":"2017","journal-title":"Sci. Signal."},{"key":"10.1016\/j.xcrm.2024.101777_bib55","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1158\/0008-5472.CAN-15-2888","article-title":"CK2alpha' drives lung cancer metastasis by targeting BRMS1 nuclear export and degradation","volume":"76","author":"Liu","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2024.101777_bib56","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2024.101777_bib57","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41592-018-0051-x","article-title":"Strelka2: fast and accurate calling of germline and somatic variants","volume":"15","author":"Kim","year":"2018","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2024.101777_bib58","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","article-title":"Pan-cancer analysis of whole genomes","volume":"578","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2024.101777_bib59","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13059-016-0893-4","article-title":"DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution","volume":"17","author":"Rosenthal","year":"2016","journal-title":"Genome Biol."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124005226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124005226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T11:01:08Z","timestamp":1731582068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379124005226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":59,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2666379124005226"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101777","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modeling lung adenocarcinoma metastases using patient-derived organoids","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101777","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101777"}}